1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Double Medical Technology, Inc. Class A

Double Medical Technology, Inc. Class A

SSZSE:002901
39.31
CNY
+0.63
(+1.63%)
1.74EPS
25.42P/E
17.30BMarket Cap
Oct 26Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.91
0.75
1.23
1.29
1.61
1.93
3.13
3.96
4.98
3.41
3.64
5.15
6.38
6.69
Basic EPS, GAAP
1.87
0.35
0.59
0.61
0.8
0.93
1.16
1.51
1.68
0.22
0.14
0.86
1.47
1.64
Free Cash Flow per Basic Share
- -
0.18
0.15
0.48
0.75
0.58
0.29
1.04
1.09
-0.37
-0.55
0.41
1.71
- -
Dividend per Share
- -
0.01
0.23
0.16
0.26
0.4
0.52
0.6
0.81
0.5
0.02
0.28
0.53
0.53
Book Value per Share
4.32
5.23
1.22
1.59
3.07
3.58
4.28
5.23
6.2
7.19
7.39
7.44
8.62
8.49
Tangible Book Value per Share
3.72
4.07
1.06
1.45
2.93
3.46
4.17
4.89
5.66
6.68
6.89
6.97
8.19
8.05
Basic Weighted Avg Shares
52
400
320
360
369
399
401
401
401
421
421
415
408
407
Sales/Revenue/Turnover
203
299
392
463
594
772
1,257
1,587
1,994
1,434
1,533
2,136
2,601
2,725
Operating Margin (%)
53.21
54.89
52.94
51.93
59.5
53.45
43.89
44.66
41.02
8.09
7.41
21.02
27.65
29.8
Depreciation Expense
- -
13
18
23
24
29
40
50
71
96
112
126
137
- -
Net Income, GAAP
97
139
189
219
296
371
465
606
673
93
59
357
600
669
Effective Tax Rate (%)
15.65
16.92
15.69
15.14
14.2
14.21
15.87
13.37
13.83
25.7
13.44
10.07
12.76
13.47
Profit Margin (%)
47.77
46.6
48.11
47.41
49.76
48.09
37.02
38.17
33.76
6.45
3.85
16.71
23.06
24.57
Working Capital
122
79
215
345
991
1,155
1,222
1,527
1,673
2,010
2,002
1,870
2,461
2,395
LT Debt
- -
- -
- -
- -
- -
- -
- -
4
14
61
272
248
301
298
Total Equity
225
274
442
580
1,239
1,458
1,753
2,134
2,588
3,106
3,161
3,182
3,685
3,596
Return on Invested Capital (%)
- -
46.75
45.39
39.02
32.66
27.72
29.59
31.25
29.23
3.76
2.59
10.58
16.97
18.42
Return on Capital (%)
- -
54.56
51.44
41.85
31.95
27.06
28.17
30.63
27.61
2.69
1.09
9.12
15.01
16.4
Return on Common Equity (%)
- -
56.24
53.07
43.3
32.82
27.85
29.45
31.66
29.17
3.36
1.95
11.63
18.04
19.95

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
12
62
122
LT Borrowings
296
294
294
LT Finance Leases
5
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
414
414
414
Market Capitalization
19,612
18,126
17,298

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,339
3,458
3,579
Cash, Cash Equivalents & STI
1,719
1,810
1,857
Accounts Receivable, Net
303
324
333
Inventories
1,235
1,240
1,297
Total Current Liabilities
878
817
1,184
Payables & Accruals
- -
- -
- -
ST Debt
12
62
122
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
26.4%
11.91%
15.83%
Free Cash Flow
57.72%
9.78%
306.09%
Net Income, GAAP
59.41%
92.37%
68.06%
Sales/Revenue/Turnover
23.11%
13.11%
21.79%
Total Cash Common Dividend
129.38%
227.39%
81.55%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
427
537
565
606
2,136
2025
550
660
- -
725
2,601
2026
641
698
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.15
0.18
0.25
0.28
0.86
2025
0.25
0.35
- -
0.43
1.47
2026
0.36
0.51
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.17
0.1
0.01
0.28
2025
0.01
0.51
- -
0.01
0.53
2026
0.01
0.01
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Jiong Luo
Full Time Employees
4,704
Sector
Health technology
Industry
Medical specialties
Address
No. 18, Shanbianhong East Road Xiamen FU China 361027
IPO Date
Sep 22, 2017
Website
double-medical.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Double Medical Technology Inc. operates as a comprehensive healthcare solutions provider, delivering advanced services, innovative technologies, and a broad portfolio of medical devices across diverse surgical fields within China. Its primary focus areas encompass orthopedics, covering trauma, spine, joint, sports medicine, and foot & ankle, alongside offerings in wound care, neurosurgery, general surgery, and dental implants. The company also maintains a significant international presence, exporting its specialized products to over 50 nations and territories globally, including regions such as Europe, Russia, South America, Australia, Southeast Asia, the Middle East, and South Africa. Founded in 2004 and headquartered in Xiamen, People's Republic of China, the firm has established itself as a leader in the domestic orthopedic implant market through continuous innovation and an extensive distribution network. Double Medical Technology Inc. was successfully listed on the Shenzhen Stock Exchange in 2017.